Nancy Ryerson

Nancy Ryerson is a digital communicator with years of experience covering healthcare. Today, she's a Digital Marketing Manager at Antidote, where she manages the company's content marketing and SEO strategies. Prior to joining Antidote, Nancy spent three years at The Michael J. Fox Foundation, where she created content for Parkinson's disease patients and expanded the Foundation's email list by 100,000+ members in two years through search and social strategies. She holds a BA in English and journalism from NYU.

Find me on:

Health Literacy Month: How Miscommunication Can Impact Health

October is Health Literacy Month. Health literacy refers to how well patients understand medical information from doctors. It plays a critical role in whether or not a patient receives the right care for them.

Continue reading

World Mental Health Day: We Need More Treatment Options – and Access

One in five adults in the U.S. experience a mental health condition each year. Of those, only 43.3% received treatment last year. This World Mental Health Day, we’re highlighting the importance of both awareness and treatment for the millions of people struggling with symptoms.

Continue reading

How to Optimize Patient Recruitment in Five Steps

Of all of the elements of a clinical trial, optimizing patient recruitment may make the most significant impact on trial timelines. Even if you're meeting your recruitment goals – a rare accomplishment, to say the least – trials and budgets always benefit from better efficiency.

Continue reading

What Type 1 Diabetes Patients Care About in Clinical Trials [Survey Results]

Clinical research organizations sometimes create surveys and share general statistics about clinical trial participation. But every patient is different, and overarching stats don't tell the full story.

Continue reading

What's the Latest Eczema Research?

Today, 70% of the 18 million adults in the U.S. experience moderate-to-severe symptoms. Nearly half of people with eczema report that they "often" or "always" feel frustrated by their disease. One-third report that they spend up to three hours per day treating their disease.

Continue reading

What's next for Alzheimer's research?

An estimated 5.8 million people in the United States have been diagnosed with Alzheimer's disease. As the millions of patients and caregivers around the country know too well, there is not a treatment option that slows or stops disease progression.

Continue reading

The Science of Clinical Trial Selection: Why Trial Type Matters to Patients

Living with a chronic illness or other condition can take up a significant piece of a patient's time. Though clinical trials can be beneficial to patients, recruitment efforts have to compete with many other products and services that can offer a patient support.

Continue reading

Autoimmune hepatitis diet: What do doctors recommend?

While there is no recommended diet for autoimmune hepatitis, diet considerations related to weight management and alcohol consumption may make an impact on both symptoms and disease progression. Following a healthy diet and talking with your doctor about alcohol consumption can help you avoid complications related to obesity, reduce weight gain from common steroid treatments, and avoid ...

Continue reading

The Best Clinical Trial Recruitment Strategies for Fast Results

As a clinical trial sponsor, you don't have time to waste. Running a clinical trial for one day can cost up to $37,000 by some estimations. Delays in new treatments hurt patients waiting for better options, too.

Continue reading

Asthma Research Round-Up: July 2019

Today, nearly 25 million people in the United States are living with asthma. For 5 to 10% of those living with asthma, symptoms such as wheezing and shortness of breath aren't well managed by their current treatments.

Continue reading

Get our latest posts in your inbox